What Happened?
Raleigh, NC-based BioDelivery-Sciences-International Appointed John Golubieski as Chief Financial Officer
About the Company
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs.
About the Person
John Golubieski is Chief Financial Officer at BioDelivery Sciences International. Previously, John held various senior HR leadership roles in the industry.
Info Source
News
Short Profile